Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia

Journal of the American Medical Directors Association
Andrea D FoebelRosa Liperoti

Abstract

To explore antipsychotic (AP) medications and physical restraint use and their effects on physical function and cognition in older nursing home residents. This retrospective cohort studied involved 532 residents with dementia from 57 nursing homes participating in the Services and Health for Elderly in Long-Term Care study. Poisson log regression models explored the effect of physical restraint and/or AP medication use on cognitive or functional decline at 6 months. Physical restraint use was associated with a higher risk of both functional and cognitive decline compared with AP medication use alone. These risks were highest among residents receiving both AP medications and physical restraints, suggesting additive effects. Physical restraint use, and even more strongly, concurrent physical restraint and AP medication use, is related to function and cognitive decline in nursing home residents with dementia. Antipsychotic use is cautioned, but these results suggest physical restraint use is potentially more risky.

References

Oct 1, 1986·Journal of the American Geriatrics Society·J Cohen-Mansfield, N Billig
Jul 1, 1994·Journal of Gerontology·J N MorrisL A Lipsitz
Jun 1, 1996·Journal of the American Geriatrics Society·E CapezutiG Maislin
Jan 5, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J N MorrisS A Morris
Oct 9, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Oscar J de VriesUNKNOWN European Academy of Medicine of Ageing-Course III
Mar 6, 2009·Geriatrics & Gerontology International·Manuel Eskildsen, Thomas Price
Mar 13, 2009·International Journal of Geriatric Psychiatry·Zhanlian FengVincent Mor
May 1, 2009·BMC Health Services Research·Leonard C GrayJohn N Morris
Feb 15, 2011·Journal of the American Geriatrics Society·Petra KoczyDoris Bredthauer
Jan 11, 2012·BMC Health Services Research·Graziano OnderUNKNOWN SHELTER project
Jul 20, 2013·Journal of Nursing Management·Carol A WongLisa Ducharme
Feb 18, 2014·Journal of the American Medical Directors Association·Ramona BackhausJan P H Hamers
Sep 30, 2014·Journal of the American Medical Directors Association·Andrea D FoebelUNKNOWN SHELTER Study Investigators

❮ Previous
Next ❯

Citations

Mar 10, 2016·Journal of the American Medical Directors Association·Patricia Abele, John E Morley
Oct 27, 2016·Journal of the American Medical Directors Association·Davide L VetranoUNKNOWN Italian Group for Appropriate Drug Prescription in the Elderly (I-GrADE)
May 8, 2018·Health Services Research·Nina R JoyceDavid C Grabowski
Jul 2, 2020·International Psychogeriatrics·Liat AyalonElitzur Bar Asher-Sigal
Mar 19, 2020·Frontiers in Psychiatry·Wendy de BruijnRoel J T Mocking
Jul 23, 2020·Revista brasileira de enfermagem·Romulo DelvallePatrícia de Fátima Augusto Barros
Jul 13, 2017·Behavioral Sciences·Christopher JohnsonRoxanna Johnson
Aug 14, 2019·International Journal of Environmental Research and Public Health·Qilin ZhangErpeng Liu
Apr 4, 2021·International Journal of Environmental Research and Public Health·Lauren M RobinsTerry P Haines
Jun 8, 2021·International Journal of Geriatric Psychiatry·Lídia SousaLia Fernandes
Jul 7, 2021·Nursing Forum·Amal Al GhassaniAbdallah Abu Khait

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of the American Geriatrics Society
L C BurtonL J Brant
JAMA : the Journal of the American Medical Association
E A Coleman
JAMA : the Journal of the American Medical Association
Florian Riese, Christoph Hock
© 2022 Meta ULC. All rights reserved